TheEdgeResearch
Home / Stocks / COCH

Envoy Medical, Inc. (COCH)

NASDAQ Healthcare Medical - Devices
$0.71 ▼ -0.15%
Market Cap
$14.9M
Sector
Healthcare
Industry
Medical - Devices
Beta
1.90
52-Wk Range
0.3625-1.89
CEO
Brent T. Lucas
Country
US
Currency
USD

Envoy Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in White Bear Lake, MN, US. The stock last traded at $0.71, down 0.15% on the session, giving a market capitalisation of $14.9M. On trailing twelve-month figures it carries a trailing P/E of -1.06, a net margin of -11304.8%. Its beta of 1.90 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-1.06
Price / Sales
71.85
Price / Book
22.52
EV / EBITDA
0.18
Gross margin
-385.5%
Operating margin
-11411.1%
Net margin
-11304.8%
Return on equity
—
Debt / equity
0.25
Current ratio
1.73
Dividend yield
0.0%
Payout ratio
-5.8%
Company profile
Exchange
NASDAQ Capital Market
Employees
43
IPO date
2021-04-29
Headquarters
White Bear Lake, MN, US
About Envoy Medical, Inc.

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.

Comparable companies

Envoy Medical, Inc. is most often compared with the following Healthcare names:

ADGMADTXALURATHACODXHCTIIRIXNVNOVSEEVVOS
More research on COCH
COCH technical analysis COCH TheEdge Score Compare against peers
Open full interactive analysis & DCF →